- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06556628
Tympanic Thermometer Study
August 14, 2024 updated by: Baxter Healthcare Corporation
Disco Thermometer Engineering Study Protocol
The goal of this study is to collect febrile, healthy, and in some instances cold temperature data from human subjects ranging from newborns to geriatrics.
This data will be used to develop a new thermometer.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
1000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Skaneateles, New York, United States, 13153
- Baxter
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Subjects recruited to participate in this study may range in age from normal weight (≥2.5kg), full-term (37 weeks gestation) newborns to geriatric adults.
The subject may be anyone who is willing to have their temperature taken who also meets the eligibility criteria.
Study subjects may have normal, febrile, or cold temperatures.
Description
Inclusion Criteria:
- Age: normal weight (≥2.5kg), full-term (37 weeks gestation) newborn to geriatric adult.
- Participant, legal guardian, or healthcare proxy is able to give consent to participate.
- Participant, legal guardian, or healthcare proxy speaks fluent English.
Exclusion Criteria:
- The subject does not meet the inclusion criteria.
- The subject has anatomical abnormalities that would affect temperature.
- The subject has blood or drainage in the external ear canal.
- The subject has had something in their ear for a prolonged period, such as a hearing aid or headphones. The subject may be included if the hearing aid or headphones are removed at least 30 minutes prior to taking ear temperature.
- The subject has been lying on ear within 30 minutes of data collection. The subject may be included if they wait 30 minutes prior to having an ear temperature measurement taken.
- The subject exhibits symptoms of an acute or chronic inflammatory condition of the external ear canal. An example would be swimmer's ear. The subject may be included if the acute or chronic inflammatory condition is isolated to one ear, then the other ear may be used for data collection.
- The subject has an ear obstruction or excess cerumen build-up.
- The subject is in acute distress, i.e., severe pain, severe emotional distress or agitation that would inhibit them from participating in a tympanic ear temperature study.
- The subject has any known contraindication to oral, ear, or axillary temperature measurements.
- The subject has used ear drops in the last 8 hours. The subject may be included if the other ear was not medicated with ear drops in the last 8 hours.
- The subject (age 5+) has consumed food or drink, or smoked, within the last 20 minutes. The subject may be included if they wait 20 minutes prior to taking oral temperature.
- The subject has taken an antipyretic (ex: Tylenol, Motrin, Aspirin) in the last 120 minutes.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Fever
Elevated oral temperature of 37.5C or higher or elevated axillary temperature of 37.2C or higher.
|
Collecting data on patients whose body temperatures increase due to fighting an illness.
|
|
Healthy
Oral temperature between 36-37.4C
Axillary temperature between 36-37.1C
|
|
|
Cold
Oral or axillary temperatures below 36C
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical Bias
Time Frame: Immediately after the diagnostic test
|
The mean difference between output temperatures of the clinical thermometer under test
|
Immediately after the diagnostic test
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Repeatability
Time Frame: Immediately after the diagnostic test
|
Pooled standard deviation (over a selected group of subjects) of changes in multiple output temperatures taken from the same subject at the same measuring site with the same clinical thermometer by the same operator within a relatively short time
|
Immediately after the diagnostic test
|
|
Limits of Agreement
Time Frame: Immediately after the diagnostic test
|
The magnitude of a potential disagreement between outputs of two clinical thermometers equal to double the standard deviation of output temperature differences when used on the same human subject.
|
Immediately after the diagnostic test
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 11, 2022
Primary Completion (Estimated)
May 31, 2025
Study Completion (Estimated)
May 31, 2025
Study Registration Dates
First Submitted
August 12, 2024
First Submitted That Met QC Criteria
August 14, 2024
First Posted (Actual)
August 16, 2024
Study Record Updates
Last Update Posted (Actual)
August 16, 2024
Last Update Submitted That Met QC Criteria
August 14, 2024
Last Verified
August 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 60117201
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fever
-
Centre Hospitalier Annecy GenevoisNot yet recruitingEmergency Call | Fever; Pediatric Fever Management; Parental AnxietyFrance
-
Karolinska InstitutetCompletedCrimean Congo Hemorrhagic FeverSweden
-
Meir Medical CenterCompleted
-
Chengdu Jinjiang Maternity and Child Health HospitalNot yet recruiting
-
Sanofi Pasteur, a Sanofi CompanyCompletedYellow Fever | Dengue | Dengue Fever | Dengue Hemorrhagic FeverUnited States
-
U.S. Army Medical Research and Development CommandBausch Health Americas, Inc.WithdrawnCrimean-Congo Hemorrhagic Fever | Lassa FeverGermany
-
Assistance Publique Hopitaux De MarseilleCompleted
-
Liverpool School of Tropical MedicineMedical Research Council; MEDEX; Mologic LtdNot yet recruitingCrimean-Congo Haemorrhagic Fever
-
Sanofi Pasteur, a Sanofi CompanyUnited States Department of DefenseCompletedDengue | Dengue Fever | Dengue Hemorrhagic FeverUnited States
-
Shaare Zedek Medical CenterCompleted
Clinical Trials on Increased Body Temperatures
-
Chung Shan Medical UniversityNot yet recruitingSupportive Care | Radiation-induced Oral Mucositis | Radiotherapy Side Effects | Nursing Interventions | Head and Neck Cancer (H&Amp;Amp;N)Taiwan
-
National Institute of Diabetes and Digestive and...Completed
-
Firat UniversityCompletedImpacted Third Molar ToothTurkey
-
Izmir Katip Celebi UniversityCompleted
-
Poznan University of Physical EducationApproved for marketingParticularly Partial-body CryostimulationPoland
-
Merck Sharp & Dohme LLCIntegrated Therapeutics GroupTerminatedRheumatoid Arthritis
-
University of UtahUniversity of Colorado, BoulderCompletedSleep Wake Disorders | Sleep Deprivation | Insufficient Sleep SyndromeUnited States
-
European Institute of OncologyCompleted
-
University of Sao Paulo General HospitalUnknownThere Are no Specific Conditions Under Study | This Study Evaluates the Clinical Decision-Making Associated With Intensive Care Units Rationing
-
University Hospital, GhentCompletedAcute Renal Failure | Chronic Renal FailureBelgium